DALLAS – August 13, 2020 – (Newswire.com)
Medicinal products derived from the hemp plant, popularly known as CBD, and produced in the United States are entering the Latin American market through the first strategic alliance of two giant companies, Medterra and Megabals, announced today simultaneously from Dallas, Texas, and Montevideo, Uruguay.
“Medical cannabis is considered the ‘green gold’ of our times, many have speculated about this growing industry, but in reality, not many companies have been able to develop products of such high quality and presentation as Medterra has,” explains Andres Giraldo, CEO and founder of Medterra Latam, a subsidiary of Medterra.
“The hemp plant is a great unknown for many, with a more than promising future. There is a tendency to confuse it with marijuana, both belong to the same species, Cannabis sativa, but there are proven differences in morphology, chemistry and purposes of use. We are sure that our products will be a phenomenal relief for thousands of people. On its own, CBD is not intoxicating, but it moderates the euphoric effect of THC. Our products have 0% THC,” said Jay Hartenbach, CEO of Medterra.
“We will start in Mexico, Argentina and Brazil, as the populations of these countries show a greater interest in high-quality CBD products. Megalabs will use its advanced distribution network throughout Latin America to continue Medterra’s global expansion,” said Gianclaudio Broggi, CEO of Megalabs, a leading pharmaceutical company positioning products in markets in many countries. “With this agreement, Megalabs is strengthening its broad portfolio and entering a new therapeutic field with CBD, which is highly effective as a treatment for pain, anxiety, depression, epilepsy, among other ailments.”
The alliance announced today is achieved thanks to the initiative of entrepreneurs of Colombian origin founders of Medterra Latam. Along with Andres Giraldo, are Jorge Giraldo, VP, and Melissa Franco, Project Director for Latin America and India.
______________________________________________________________________
Megalabs is a leading Latin American pharmaceutical company, committed to healthcare and strategically oriented towards innovation and affordable therapeutic solutions, currently present in 18 countries with more than 7,700 employees, including a highly professional sales force of more than 3,000 representatives. 24% of Latin American doctors prescribe their products and health professionals prescribe 42,000 Megalabs products every day. It is supported by 17 of its own production sites, a highly diversified portfolio with more than 1,800 products.
Medterra. A world leader in CBD products. Working with well-prepared professionals, physicians and innovators, Medterra has successfully overcome the strict and changing guidelines of the American hemp industry to be considered one of the leading brands in North America. Its oils, tinctures and creams start on hemp farms in Kentucky, where the best hemp in America has been grown for hundreds of years.
_____________________________________________________________________
MORE INFORMATION
Flavia Pebet
Manager of Therapeutic Science & Research
Megalabs
fpebet@megalabs.global
Melissa Franco
Project Director for Latin America and India
Medterra LATAM
melissa.franco@medterracbd.com
Tel. (512) 826-0682
Press Release Service
by
Newswire.com
Original Source:
Medicinal Cannabis, CBD, Enters Through the Big Door to Latin America
